Terms: = Lymphoma AND PICALM, CLTH, 8301, ENSG00000073921, CALM, Q13492
70 results:
1. Genetic Characterization of Pediatric Mixed Phenotype Acute Leukemia (MPAL).
Panagopoulos I; Andersen K; Johannsdottir IMR; Tandsæther MR; Micci F; Heim S
Cancer Genomics Proteomics; 2024; 21(1):1-11. PubMed ID: 38151288
[TBL] [Abstract] [Full Text] [Related]
2. Treatment outcomes of childhood picalm::MLLT10 acute leukaemias.
Mark C; Meshinchi S; Joyce B; Gibson B; Harrison C; Bergmann AK; Goemans BF; Pronk CJH; Lapillonne H; Leverger G; Antoniou E; Schneider M; Attarbaschi A; Dworzak M; Stary J; Tomizawa D; Ebert S; Lejman M; Kolb EA; Schmiegelow K; Hasle H; Abla O
Br J Haematol; 2024 Feb; 204(2):576-584. PubMed ID: 37743097
[TBL] [Abstract] [Full Text] [Related]
3. Clinical Pharmacology and Determinants of Response to UCART19, an Allogeneic Anti-CD19 CAR-T Cell Product, in Adult B-cell Acute Lymphoblastic Leukemia.
Dupouy S; Marchiq I; Derippe T; Almena-Carrasco M; Jozwik A; Fouliard S; Adimy Y; Geronimi J; Graham C; Jain N; Maus MV; Mohty M; Boissel N; Teshima T; Kato K; Benjamin R; Balandraud S
Cancer Res Commun; 2022 Nov; 2(11):1520-1531. PubMed ID: 36970059
[TBL] [Abstract] [Full Text] [Related]
4. UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (calm): a phase 1, dose-escalation trial.
Benjamin R; Jain N; Maus MV; Boissel N; Graham C; Jozwik A; Yallop D; Konopleva M; Frigault MJ; Teshima T; Kato K; Boucaud F; Balandraud S; Gianella-Borradori A; Binlich F; Marchiq I; Dupouy S; Almena-Carrasco M; Pannaux M; Fouliard S; Brissot E; Mohty M;
Lancet Haematol; 2022 Nov; 9(11):e833-e843. PubMed ID: 36228643
[TBL] [Abstract] [Full Text] [Related]
5. Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins.
Steimlé T; Dourthe ME; Alcantara M; Touzart A; Simonin M; Mondesir J; Lhermitte L; Bond J; Graux C; Grardel N; Cayuela JM; Arnoux I; Gandemer V; Balsat M; Vey N; Macintyre E; Ifrah N; Dombret H; Petit A; Baruchel A; Ruminy P; Boissel N; Asnafi V
Blood Cancer J; 2022 Jan; 12(1):14. PubMed ID: 35082269
[TBL] [Abstract] [Full Text] [Related]
6. [Lineage switch from T-lymphoblastic leukemia to myeloid leukemia at relapse].
Kuze A; Ida N; Hosono N; Negoro E; Yamauchi T
Rinsho Ketsueki; 2021; 62(7):721-726. PubMed ID: 34349054
[TBL] [Abstract] [Full Text] [Related]
7. IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT calm (Collaboration to Collect Autologous Transplant Outcomes in lymphomas and Myeloma) Study.
Lawless S; Sbianchi G; Morris C; Iacobelli S; Bosman P; Blaise D; Reményi P; Byrne JL; Mayer J; Apperley J; Lund J; Kobbe G; Schaap N; Isaksson C; Lenhoff S; Basak G; Touzeau C; Wilson KMO; González Muñiz S; Scheid C; Browne P; Anagnostopoulos A; Rambaldi A; Jantunen E; Kröger N; Schönland S; Yakoub-Agha I; Garderet L
Clin Lymphoma Myeloma Leuk; 2021 Oct; 21(10):686-693. PubMed ID: 34158265
[TBL] [Abstract] [Full Text] [Related]
8. Molecular and phenotypic characterization of an early T-cell precursor acute lymphoblastic lymphoma harboring picalm-MLLT10 fusion with aberrant expression of B-cell antigens.
Khurana S; Melody ME; Ketterling RP; Peterson JF; Luoma IM; Vazmatzis G; Tun HW; Foran JM; Jiang L
Cancer Genet; 2020 Jan; 240():40-44. PubMed ID: 31739126
[TBL] [Abstract] [Full Text] [Related]
9. Detection of novel fusion-transcripts by RNA-Seq in T-cell lymphoblastic lymphoma.
López-Nieva P; Fernández-Navarro P; Graña-Castro O; Andrés-León E; Santos J; Villa-Morales M; Cobos-Fernández MÁ; González-Sánchez L; Malumbres M; Salazar-Roa M; Fernández-Piqueras J
Sci Rep; 2019 Mar; 9(1):5179. PubMed ID: 30914738
[TBL] [Abstract] [Full Text] [Related]
10. Mediastinal Myeloid Sarcoma with TP53 Mutation Preceding Acute Myeloid Leukemia with a picalm-MLLT10 Fusion Gene.
Naesens L; Devos H; Nollet F; Michaux L; Selleslag D
Acta Haematol; 2018; 140(2):97-104. PubMed ID: 30227397
[TBL] [Abstract] [Full Text] [Related]
11. Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents.
Sahebi F; Iacobelli S; Sbianchi G; Koster L; Blaise D; Reményi P; Russell NH; Ljungman P; Kobbe G; Apperley J; Trneny M; Krejci M; Wiktor-Jedrzejczak W; Sanchez JF; Schaap N; Isaksson C; Lenhoff S; Browne P; Scheid C; Wilson KMO; Yakoub-Agha I; Muñiz SG; Schönland S; Morris C; Garderet L; Kröger N
Biol Blood Marrow Transplant; 2018 May; 24(5):930-936. PubMed ID: 29339268
[TBL] [Abstract] [Full Text] [Related]
12. Melphalan 140 mg/m
Auner HW; Iacobelli S; Sbianchi G; Knol-Bout C; Blaise D; Russell NH; Apperley JF; Pohlreich D; Browne PV; Kobbe G; Isaksson C; Lenhoff S; Scheid C; Touzeau C; Jantunen E; Anagnostopoulos A; Yakoub-Agha I; Tanase A; Schaap N; Wiktor-Jedrzejczak W; Krejci M; Schönland SO; Morris C; Garderet L; Kröger N
Haematologica; 2018 Mar; 103(3):514-521. PubMed ID: 29217776
[TBL] [Abstract] [Full Text] [Related]
13. Successful Treatment of a Very Late Isolated Relapse in an Adolescent With a picalm-MLLT10 Positive T-lineage Acute Lymphoblastic Leukemia.
Cannata E; Samperi P; Cimino C; Marino S; Sullo F; Mirabile E; Di Cataldo A; Russo G; Lo Nigro L
J Pediatr Hematol Oncol; 2018 Apr; 40(3):e191-e194. PubMed ID: 29189509
[TBL] [Abstract] [Full Text] [Related]
14. Combinational Analysis of FISH and Immunohistochemistry Reveals Rare Genomic Events in ALK Fusion Patterns in NSCLC that Responds to Crizotinib Treatment.
Li W; Zhang J; Guo L; Chuai S; Shan L; Ying J
J Thorac Oncol; 2017 Jan; 12(1):94-101. PubMed ID: 27614248
[TBL] [Abstract] [Full Text] [Related]
15. CATS (FAM64A) abnormal expression reduces clonogenicity of hematopoietic cells.
Barbutti I; Xavier-Ferrucio JM; Machado-Neto JA; Ricon L; Traina F; Bohlander SK; Saad ST; Archangelo LF
Oncotarget; 2016 Oct; 7(42):68385-68396. PubMed ID: 27588395
[TBL] [Abstract] [Full Text] [Related]
16. CCI-007, a novel small molecule with cytotoxic activity against infant leukemia with MLL rearrangements.
Somers K; Chudakova DA; Middlemiss SM; Wen VW; Clifton M; Kwek A; Liu B; Mayoh C; Bongers A; Karsa M; Pan S; Cruikshank S; Scandlyn M; Hoang W; Imamura T; Kees UR; Gudkov AV; Chernova OB; Haber M; Norris MD; Henderson MJ
Oncotarget; 2016 Jul; 7(29):46067-46087. PubMed ID: 27317766
[TBL] [Abstract] [Full Text] [Related]
17. Characterization and inhibition of AF10-mediated interaction.
Hagen S; Mattay D; Räuber C; Müller KM; Arndt KM
J Pept Sci; 2014 Jun; 20(6):385-97. PubMed ID: 24692230
[TBL] [Abstract] [Full Text] [Related]
18. Choroidal lymphoma shows calm, rippled, or undulating topography on enhanced depth imaging optical coherence tomography in 14 eyes.
Shields CL; Arepalli S; Pellegrini M; Mashayekhi A; Shields JA
Retina; 2014 Jul; 34(7):1347-53. PubMed ID: 24569490
[TBL] [Abstract] [Full Text] [Related]
19. The prognosis of calm-AF10-positive adult T-cell acute lymphoblastic leukemias depends on the stage of maturation arrest.
Ben Abdelali R; Asnafi V; Petit A; Micol JB; Callens C; Villarese P; Delabesse E; Reman O; Lepretre S; Cahn JY; Guillerm G; Berthon C; Gardin C; Corront B; Leguay T; Béné MC; Ifrah N; Leverger G; Dombret H; Macintyre E
Haematologica; 2013 Nov; 98(11):1711-7. PubMed ID: 23831922
[TBL] [Abstract] [Full Text] [Related]
20. New MLLT10 gene recombinations in pediatric T-acute lymphoblastic leukemia.
Brandimarte L; Pierini V; Di Giacomo D; Borga C; Nozza F; Gorello P; Giordan M; Cazzaniga G; Te Kronnie G; La Starza R; Mecucci C
Blood; 2013 Jun; 121(25):5064-7. PubMed ID: 23673860
[TBL] [Abstract] [Full Text] [Related]
[Next]
